In particular, CCR6+ TH cell proportions were higher in ACPA-positive RA patients in comparison to ACPA-negative RA patients, and inversely correlated with disease duration in ACPA-negative patients. This evidence concerns the gene PRTN3 and rheumatoid arthritis.